Skip to content

IDT Corporation IDT Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

CBIZ logo
CBIZCBZ
$3.64M-56.7%
AMN Healthcare logo
AMN HealthcareAMN
$2.51M-65.4%
GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$2.61M-56.0%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$35.7M-66.2%
SS&C Technologies logo
SS&C TechnologiesSSNC
$7.6M+7,500%
Mercado Libre logo
Mercado LibreMELI
$3.61B-7.5%

Other financials

Income statement

See full
Revenue$315.7M+4.5%
Gross profit$121.3M+8.2%
Operating income$27.2M-3.8%
Net income$23.7M+9.5%
EPS (diluted)$0.84+5.0%

Balance sheet

See full
Cash & equivalents$215.0M-33.5%
Total debt$1.4M-34.0%
Total equity$357.9M+25.1%
Total assets$698.0M+16.2%

Cash flow

See full
Operating cash flow$18.5M-75.6%
CapEx$5.1M-5.7%
Free cash flow$13.4M-81.0%

Valuation

See full
Market cap$1.38B-14.8%
Enterprise value$1.17B-10.3%
P/E16.5×-0.4×
P/S1.1×-0.2×

Profitability

See full
Gross margin36.9%+2.6pp
Operating margin8.5%+1.6pp
Net margin6.6%-1.3pp
FCF margin4.3%-3.9pp

Returns & leverage

See full
Return on equity26.1%-12.3pp
Debt / equity0.0×
Current ratio1.9×+0.2×

Where this comes from

Reported directly by IDT Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: IDT Corporation’s 10-Q, filed March 13, 2017, on SEC EDGAR. View the filing →